U.S. Biotechs Line Up to List in Korea Amid Jump in Share Prices

Bookmark
(Bloomberg) -- U.S. biotech firms are queuing up to list in South Korea, tempted by the promise of strong valuations amid a welcoming base of investors.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.